Newron Sweden AB clinical trials
Acquired by Newron Pharmaceuticals SPA, Dec 17, 2012 · source ↗
The registry lists 8 studies whose lead sponsor is Newron Sweden AB. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 27, 2016.
Before and after it joined Newron Pharmaceuticals SPA
- First submitted before Newron Sweden AB became part of Newron Pharmaceuticals SPA
- 3
- First submitted after Newron Sweden AB became part of Newron Pharmaceuticals SPA
- 5
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Newron Sweden AB8 studies
Something wrong with this grouping? Tell us on the Newron Pharmaceuticals SPA page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All Newron Pharmaceuticals SPA studies →
- Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PDTerminatedNCT02408562Phase 1/2
Sponsor listed in the registry: Newron Sweden AB · First submitted after Newron Sweden AB became part of Newron Pharmaceuticals SPA
- An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral SclerosisTerminatedNCT01384162Phase 1/2
Sponsor listed in the registry: Newron Sweden AB · First submitted before Newron Sweden AB became part of Newron Pharmaceuticals SPA
- A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.TerminatedNCT01829867Phase 1
Sponsor listed in the registry: Newron Sweden AB · First submitted after Newron Sweden AB became part of Newron Pharmaceuticals SPA
- A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALSTerminatedNCT01999803Phase 1
Sponsor listed in the registry: Newron Sweden AB · First submitted after Newron Sweden AB became part of Newron Pharmaceuticals SPA
- A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALSTerminatedNCT02269436Phase 1
Sponsor listed in the registry: Newron Sweden AB · First submitted after Newron Sweden AB became part of Newron Pharmaceuticals SPA
- A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's DiseaseCompletedNCT00866502Phase 1/2
Sponsor listed in the registry: Newron Sweden AB · First submitted before Newron Sweden AB became part of Newron Pharmaceuticals SPA
- A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's DiseaseCompletedNCT01807338
Sponsor listed in the registry: Newron Sweden AB · First submitted after Newron Sweden AB became part of Newron Pharmaceuticals SPA
- A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral SclerosisCompletedNCT00800501Phase 1/2
Sponsor listed in the registry: Newron Sweden AB · First submitted before Newron Sweden AB became part of Newron Pharmaceuticals SPA